82VS — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Aakhaaakha.bioinJul 2024
Aakha Bio develops multi-specific antibodies for solid tumors that block disease pathways and activate immune cells.
BiotechHealthtechMedical DevicesFrisco, US
Hemanta Baruah(Founder & CEO)in
BoardErrik Anderson(Director)inChristopher Pacheco(Director)George Robert Mabry III(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.